Angel investor
Every published round Dr Nick Engerer took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Ovum | Pre-seed | 4 Feb 2025 | $1.7m | Participant | Startup Daily (23 Jun 2026), Women's Agenda (23 Jun 2026), Forbes Australia (23 Jun 2026), Dealroom, Startup Daily (16 Jun 2026), Startup Daily (22 Jul 2025), Women's Agenda (5 Jun 2025), Women's Agenda (4 Apr 2025), Startup Daily (4 Feb 2025), Forbes Australia (4 Feb 2025) |
Companies Dr Nick Engerer has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Ovum | AI-powered women's health platform building a longitudinal health dataset. | 4 Feb 2025, Pre-seed | 1 | 0 |
Fund closes reported for Dr Nick Engerer, as distinct from the investments it has made.
Companies Dr Nick Engerer has backed that another company then bought. An exit for the holding, not a deal Dr Nick Engerer did.
| Role | Organisation | Sources |
|---|---|---|
| No role recorded yet. Dr Nick Engerer has been mentioned, but not yet attached to an organisation. Know their role? | ||
Stories naming Dr Nick Engerer. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Ovum, an app for tracking menstrual and women's health, has secured $1.7m to launch its AI assistant, in a round led by Giant Leap with Antler, Wollemi Capital and other backers.
Also Forbes Australia·Startup Daily·Startup Daily·Startup Daily·Women's Agenda·Women's Agenda·Dealroom·Forbes Australia·Women's Agenda
Norwegian energy assurance firm DNV has acquired Sydney solar forecasting company Solcast, founded in 2016 by James Luffman and Nick Engerer, to expand its global data analytics offering.